Genetic and Multi-omic Risk Assessment of Alzheimer’s Disease Implicates Core Associated Biological Domains

Author:

Cary Greg A1,Wiley Jesse C2ORCID,Gockley Jake2,Keegan Stephen1,Ganesh Sruthi2,Heath Laura2,III Robert R Butler3,Mangravite Lara M2,Logsdon Ben A2,Longo Frank M3,Levey Allan I4,Greenwood Anna K2,Carter Gregory W1

Affiliation:

1. JAX: The Jackson Laboratory

2. Sage Bionetworks

3. Stanford University School of Medicine

4. Emory University School of Medicine

Abstract

Abstract Background: Alzheimer’s disease (AD) is the predominant dementia globally, with heterogeneous presentation and penetrance of clinical symptoms, variable presence of mixed pathologies, potential disease subtypes, and numerous associated endophenotypes. However, there is no methodology to objectively rank endophenotypes for disease risk, nor to enumerate the genes associated with each endophenotype at a genome scale. Consequently, therapeutic development is challenged by the uncertainty of which endophenotypic areas, and specific subordinate targets, to prioritize for further translational research. Methods: Here we report the development of an informatic pipeline that ranks genes for AD risk genome wide and organizes them into disease associated endophenotypes--which we call AD biological domains. The AD risk ranking draws from genetic association studies, predicted variant impact, and linkage with dementia associated phenotypes to create a genetic risk score. This is paired with a multi-omic risk score utilizing extensive sets of both transcriptomic and proteomic studies to identify systems level changes in expression associated with AD. These two elements combined constitute our target risk score (TRS) that ranks AD risk genome wide. The ranked genes are organized into endophenotypic space through the development of 19 biological domains associated with AD in the described genetics and genomics studies and accompanying literature. The biological domains are constructed from exhaustive gene ontology (GO) term compilations, allowing automated assignment of genes into objectively defined disease-associated biology. This rank and organize approach, performed genome-wide, allows the characterization of aggregations of AD risk across biological domains. Results: The top AD-risk associated biological domains are Synapse, Immune Response, Lipid Metabolism, Mitochondrial Metabolism, Structural Stabilization, and Proteostasis, with slightly lower levels of risk enrichment present within the other 13 biological domains. Synapse and Mitochondrial Metabolism are the most down-regulated biological domains, with mitochondrial function being the most enriched, while Immune Response is the most up-regulated biological domain. Conclusions: The TRS ranked genes which are organized into the biological domains provides an objective methodology that can be automated into workflows to localize risk within specific biological endophenotypes, and drill down into the most significantly associated sets of GO-terms and annotated genes for potential therapeutic targets.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3